What does ACS stand for?

Food and Drug Administration (FDA) for ticagrelor, an investigational oral antiplatelet treatment for the reduction of major adverse cardiac events in patients with acute coronary syndrome (ACS).

Research has shown that visceral fat is a source of inflammation that contributes to premature atherosclerosis and risk of acute coronary syndrome.

Evidence from Scotland confirmed a 17% decrease in admission for Acute Coronary Syndrome in studied hospitals after the smoke-free legislation was introduced there.

Their main outcome measures were death due to coronary heart disease or non-fatal acute coronary syndrome during nearly 2.

risk factor counting, metabolic syndrome (and its treatment and risks), statins for all acute coronary syndrome cases, CAD risk equivalents, treatment for dyslipidemia in children and adolescents, when LDL-c is too low, the statin-treated patient with myalgia, the "rubber chicken" treatment, dietary supplements, timing for treatment, liver toxicity in medications, and whether elderly patients should receive lipid-lowering treatment.

The study looked at hospitalizations linked to acute coronary syndrome at nine Scottish hospitals in the 10 months before and after enactment of a smoke-free indoor air law.

Other sensitive criteria of LMCA disease are ST deviation in V6-V1[greater than or equal to]0 and V6/V1[greater than or equal to]1 described by Mahajan et al (3) in the largest series of electrocardiography analysis on acute coronary syndrome resulting from culprit LMCA lesion.

In high-risk secondary prevention settings such as acute coronary syndrome patients being treated with statin therapy, achieving low levels of plasma hsCRP concentration appears to be of similar importance as achieving low levels of LDL cholesterol.